GB0408752D0 - Therapeutic treatment - Google Patents

Therapeutic treatment

Info

Publication number
GB0408752D0
GB0408752D0 GBGB0408752.4A GB0408752A GB0408752D0 GB 0408752 D0 GB0408752 D0 GB 0408752D0 GB 0408752 A GB0408752 A GB 0408752A GB 0408752 D0 GB0408752 D0 GB 0408752D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic treatment
therapeutic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0408752.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamlet Pharma AB
Original Assignee
HAMLET Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAMLET Ltd filed Critical HAMLET Ltd
Priority to GBGB0408752.4A priority Critical patent/GB0408752D0/en
Publication of GB0408752D0 publication Critical patent/GB0408752D0/en
Priority to PCT/IB2005/001255 priority patent/WO2005102382A1/en
Priority to CNA2005800192369A priority patent/CN1980688A/zh
Priority to EP05733445A priority patent/EP1765383A1/en
Priority to JP2007509007A priority patent/JP2007533728A/ja
Priority to US11/578,835 priority patent/US20070232550A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB0408752.4A 2004-04-20 2004-04-20 Therapeutic treatment Ceased GB0408752D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0408752.4A GB0408752D0 (en) 2004-04-20 2004-04-20 Therapeutic treatment
PCT/IB2005/001255 WO2005102382A1 (en) 2004-04-20 2005-04-20 Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections
CNA2005800192369A CN1980688A (zh) 2004-04-20 2005-04-20 使肿瘤细胞致死的人α－乳清蛋白(HAMLET)在治疗病毒感染中的应用
EP05733445A EP1765383A1 (en) 2004-04-20 2005-04-20 Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections
JP2007509007A JP2007533728A (ja) 2004-04-20 2005-04-20 ウイルス感染を治療するためのｈａｍｌｅｔ（腫瘍細胞に致死的なヒトアルファ−ラクトアルブミン）の使用
US11/578,835 US20070232550A1 (en) 2004-04-20 2005-04-20 Use of Hamlet (Human Alpha-Lactalbumin Made Lethal to Tumour Cells) for Treating Viral Infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0408752.4A GB0408752D0 (en) 2004-04-20 2004-04-20 Therapeutic treatment

Publications (1)

Publication Number Publication Date
GB0408752D0 true GB0408752D0 (en) 2004-05-26

Family

ID=32344046

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0408752.4A Ceased GB0408752D0 (en) 2004-04-20 2004-04-20 Therapeutic treatment

Country Status (6)

Country Link
US (1) US20070232550A1 (enExample)
EP (1) EP1765383A1 (enExample)
JP (1) JP2007533728A (enExample)
CN (1) CN1980688A (enExample)
GB (1) GB0408752D0 (enExample)
WO (1) WO2005102382A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113855787A (zh) * 2020-06-30 2021-12-31 北京大学 乳清蛋白作为冠状病毒广谱抑制剂的用途
CN120860182A (zh) * 2021-08-31 2025-10-31 合生元（广州）健康产品有限公司 用于抑制冠状病毒的组合物及其应用
CN113827707B (zh) * 2021-09-30 2023-12-05 北京大学 a-乳白蛋白在抑制冠状病毒中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment

Also Published As

Publication number Publication date
JP2007533728A (ja) 2007-11-22
US20070232550A1 (en) 2007-10-04
EP1765383A1 (en) 2007-03-28
WO2005102382A1 (en) 2005-11-03
CN1980688A (zh) 2007-06-13

Similar Documents

Publication Publication Date Title
GB0316912D0 (en) Therapeutic treatment
GB0320806D0 (en) Therapeutic treatment
GB0428180D0 (en) Combination therapy
GB0417481D0 (en) Combination therapy
IL177155A0 (en) Therapeutic combinations
GB0424339D0 (en) Combination therapy
GB2430002B (en) Well treatment
GB0329275D0 (en) Therapeutic treatment
GB0307863D0 (en) Therapeutic treatment
GB0425854D0 (en) Therapeutic treatment
GB2420976B (en) Therapeutic implant
GB0426141D0 (en) Treatment
GB0424085D0 (en) Well treatment
GB0313772D0 (en) Therapeutic treatment
GB0408752D0 (en) Therapeutic treatment
GB0701549D0 (en) Skin treatment
GB0417666D0 (en) Muscle treatment
GB0404339D0 (en) Therapeutic treatment
GB0425281D0 (en) Therapeutic treatment
GB0420265D0 (en) Therapeutic treatment
GB0404358D0 (en) Therapeutic treatment
GB0421436D0 (en) Combination therapy
GB0421438D0 (en) Combination therapy
GB0419703D0 (en) Medical treatment
GB0415318D0 (en) Medical treatment

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: HAMLET PHARMA AB

Free format text: FORMER APPLICANT(S): HAMLET LTD

AT Applications terminated before publication under section 16(1)